Comparing tests to tell intestinal TB from Crohn's disease
Part of Digestive system clinical trials.
This study looks at different scoring systems to help doctors tell the difference between intestinal tuberculosis (a bacterial infection) and Crohn's disease (a chronic inflammatory condition). If you have ulcers in your ileum or colon and are undergoing a colonoscopy, you may be able to help doctors improve how they diagnose these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having a colonoscopy and have been found to have ulcers in your ileum (the last part of the small intestine) or colon (large intestine).
- Tissue samples from your ileum or colon have been sent for tuberculosis tests, including a stain for acid-fast bacilli (a type of bacteria), PCR (a genetic test), and culture (growing the bacteria in a lab).
- You have been diagnosed with either intestinal tuberculosis (a TB infection in the gut) or Crohn's disease (a chronic inflammatory bowel disease).
- If you have intestinal TB, your diagnosis is based on finding certain bacteria or a positive response to TB treatment. If you have Crohn's disease, your diagnosis is based on a combination of clinical, colonoscopy, biopsy, and imaging findings.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
This study looks at whether a simple test can help doctors tell the difference between conditions that cause long-term gut problems, like irritable bowel syndrome (a functional disorder) and inflammatory bowel disease (a disease that causes inflammation). It aims to find a way to diagnose without invasive procedures, which could lead to faster and more comfortable diagnosis for patients.
This study looks at how doctors diagnose inflammatory bowel disease (IBD), a condition that causes inflammation in the digestive tract. It may help improve diagnosis and care for people with IBD.
This trial compares different diagnostic tests to find the best way to detect cytomegalovirus (CMV) organ disease in people with inflammatory bowel disease (IBD) whose symptoms get worse and need hospital care. The goal is to improve diagnosis and treatment for this complication.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.